Results 121 to 130 of about 47,015 (158)

MASLD: Spatial Mechanisms and New Therapeutics. [PDF]

Biomolecules
Stoess C, Onyuru J, Hu Y, Jiang Y, Xin Z, Panchal A, Hartmann P.   +6 more
europepmc   +1 more source

Metabolic dysfunction-associated steatotic liver disease and immune checkpoint inhibitor response in gastrointestinal liver metastases: current evidence and future directions. [PDF]

Front Nutr
Guo S, Liu B, Li H, Yu Y, Xu J.
europepmc   +1 more source

The new era of MASH pharmacotherapy: a comprehensive review of FDA-approved and emerging agents. [PDF]

Front Gastroenterol (Lausanne)
Qasim A, Alataa R, Veena F, Shehi E.
europepmc   +1 more source

Is primary care the 'right care' for respiratory medicine in Africa? [PDF]

Afr J Prim Health Care Fam Med
Mash RJ.
europepmc   +1 more source

Hepatology: Emerging Paradigms in MASLD, Viral Hepatitis, Cholestatic Liver Disease, Portal Hypertension and Hepatocellular Carcinoma: Summary of the First Annual Paris International Liver Meeting 2026. [PDF]

Liver Int
Younossi ZM, Papatheodoridis G, Tsochatzis E, Buti M, Rimassa L, Pinzani M, Lleo A, Shawcross D, Tacke F, Wong VW, Zelber-Sagi S, Kremer AE, J Pinato D, M Llovet J, Angeli P, Asselah T, Pugliese N, Caussy C, Berzigotti A, Lampertico P, Cornberg M, Israelsen M, Gines P, Lens S, Hagström H, Trauner M, Brennan P, Boursier J, Brunetto M, Thursz M, Bugianesi E, Carette C, Degasperi E, Durand F, Dufour JF, Francque S, Francoz C, Gautier JF, Hernandez-Evole H, Jones D, Michel M, Moreno C, Mouillot T, Parlati L, Pawlotsky JM, Rautou PE, Reiberger T, Roux O, Betel M, Thabut D, Noureddin M, Vilgrain V, Vuille-Lessard E, Yilmaz Y, Gadano A, Ratziu V, Schattenberg JM, Bataller R, Serfaty L, Thiele M, Aghemo A, Castera L.   +61 more
europepmc   +1 more source

Upcycling waste apples into platform chemicals: pilot-scale production of lactic and succinic acids. [PDF]

Biotechnol Biofuels Bioprod
Portugal Rios da Costa Pereira L, Schneider R, Olszewska-Widdrat A, Sturm B, Kaetzl K.   +4 more
europepmc   +1 more source

An Efferocytosis-Associated Gene Signature for Identifying At-Risk MASH: Transcriptomic and Exploratory Plasma Biomarker Assessment. [PDF]

Genes (Basel)
Jiang J, Mao X, Lou W, Lou W, Li Z, Zhang X, Xie Q, Lai R.   +7 more
europepmc   +1 more source

Noninvasive Detection of MASH and Fibrotic Burden Using Ultrasound-Derived LIID and LSM in MASLD: A Multicenter Study. [PDF]

J Gastroenterol Hepatol
Gao F, Zhang Y, Ding Y, Li Y, Li J, Sun Y, Xue F, Chen G, Chang L, Zhong B, Yang Y, Chen C, Fu Q, Lu L, Xu Y, Fan J, Shi J, Zhou Y, Zhang X, Zheng MH, Wei L.   +20 more
europepmc   +1 more source

Hepatocyte-Specific Deficiency of Endoplasmic Reticulum-Associated Degradation Induces Coordinated Innate-Adaptive Immune Responses. [PDF]

Cells
Liu Q, Wang J, Zong H, Ma H, Li M, Wang M, Wu D, Zheng S, Wang H, Long Q.   +9 more
europepmc   +1 more source

Bile acid-axis dysregulation in MASLD/MASH progression: from metabolic mismatch to inflammatory-fibrotic remodeling. [PDF]

Front Med (Lausanne)
Du Y, Qi L, Shi Y, Huang X, Shi X, Liu M, Fang Y, Hu X.   +7 more
europepmc   +1 more source